Catalyst Pharma sees net price of drug, once free, topping $300,000
February 11, 2019 at 14:58 PM EST
Catalyst Pharmaceuticals Inc said on Monday that it expects its drug for a rare disease, which had long been available to patients for free, will cost more than $300,000 per year including rebates to insurers and other discounts.
